Gp Act Iii Acquisition Stock Market Value
| GPAT Stock | 10.11 0.03 0.30% |
| Symbol | GPAT |
GP Act III Price To Book Ratio
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GP Act. If investors know GPAT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GP Act listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.15 |
The market value of GP Act III is measured differently than its book value, which is the value of GPAT that is recorded on the company's balance sheet. Investors also form their own opinion of GP Act's value that differs from its market value or its book value, called intrinsic value, which is GP Act's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GP Act's market value can be influenced by many factors that don't directly affect GP Act's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GP Act's value and its price as these two are different measures arrived at by different means. Investors typically determine if GP Act is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GP Act's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GP Act 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GP Act's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GP Act.
| 01/31/2024 |
| 11/26/2024 |
If you would invest 0.00 in GP Act on January 31, 2024 and sell it all today you would earn a total of 0.00 from holding GP Act III Acquisition or generate 0.0% return on investment in GP Act over 300 days. GP Act is related to or competes with Prudential Financial, MetLife, Unum, Manulife Financial, Prudential Public, CNO Financial, and Brighthouse Financial. GP Act is entity of United States. It is traded as Stock on NASDAQ exchange. More
GP Act Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GP Act's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GP Act III Acquisition upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1815 | |||
| Information Ratio | (0.96) | |||
| Maximum Drawdown | 0.8962 | |||
| Value At Risk | (0.1) | |||
| Potential Upside | 0.1996 |
GP Act Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GP Act's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GP Act's standard deviation. In reality, there are many statistical measures that can use GP Act historical prices to predict the future GP Act's volatility.| Risk Adjusted Performance | 0.0331 | |||
| Jensen Alpha | (0.0004) | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.63) | |||
| Treynor Ratio | 0.1058 |
GP Act III Backtested Returns
Currently, GP Act III Acquisition is very steady. GP Act III retains Efficiency (Sharpe Ratio) of 0.12, which attests that the entity had a 0.12% return per unit of price deviation over the last 3 months. We have found twenty-eight technical indicators for GP Act, which you can use to evaluate the volatility of the firm. Please check out GP Act's Market Risk Adjusted Performance of 0.1158, variance of 0.0143, and Downside Deviation of 0.1815 to validate if the risk estimate we provide is consistent with the expected return of 0.0143%. GP Act has a performance score of 9 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.0342, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GP Act's returns are expected to increase less than the market. However, during the bear market, the loss of holding GP Act is expected to be smaller as well. GP Act III today owns a risk of 0.12%. Please check out GP Act III Acquisition standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if GP Act III Acquisition will be following its current price history.
Auto-correlation | 0.00 |
No correlation between past and present
GP Act III Acquisition has no correlation between past and present. Overlapping area represents the amount of predictability between GP Act time series from 31st of January 2024 to 29th of June 2024 and 29th of June 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GP Act III price movement. The serial correlation of 0.0 indicates that just 0.0% of current GP Act price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
GP Act III lagged returns against current returns
Autocorrelation, which is GP Act stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GP Act's stock expected returns. We can calculate the autocorrelation of GP Act returns to help us make a trade decision. For example, suppose you find that GP Act has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GP Act regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GP Act stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GP Act stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GP Act stock over time.
Current vs Lagged Prices |
| Timeline |
GP Act Lagged Returns
When evaluating GP Act's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GP Act stock have on its future price. GP Act autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GP Act autocorrelation shows the relationship between GP Act stock current value and its past values and can show if there is a momentum factor associated with investing in GP Act III Acquisition.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.